A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

NCT00876915 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

218

Enrollment

OTHER

Sponsor class

Stopped slow enrollment and lack of continuing funds

Conditions

Venous Thromboembolism
Pulmonary Embolism

Interventions

DRUG: dalteparin injection

Sponsor

University of Rochester

Collaborators

[object Object]
[object Object]